Income Statement

Revenue

+16%

+82%

10Y

Currency: USD

	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	14	14	13	13	14	14	16	18	20	22	22	22	23	23	22	17	13	8	4	3	2	0	2	9	0	0	15	13	27	30	34	42	53	59	63	61	57	53	49	55	62	69	75	75	78	80	81	81	77	0	0	0	93	23	48	77	106	111	156	221	281	323	317	307	300	314	338	345	355	359	359	353	344	336	315	298
Revenue	45 N/A	49 +9%	52 +7%	62 +19%	65 +5%	66 +1%	67 +2%	63 -6%	68 +7%	75 +11%	97 +29%	110 +14%	128 +17%	142 +10%	145 +2%	159 +10%	174 +9%	190 +9%	214 +13%	242 +13%	272 +12%	324 +19%	384 +18%	486 +27%	586 +21%	680 +16%	764 +12%	820 +7%	872 +6%	923 +6%	1 006 +9%	1 081 +7%	1 173 +9%	1 235 +5%	1 278 +3%	1 312 +3%	1 325 +1%	1 352 +2%	1 399 +4%	1 432 +2%	1 488 +4%	1 528 +3%	1 541 +1%	1 579 +2%	1 619 +3%	1 687 +4%	1 793 +6%	1 851 +3%	1 891 +2%	1 955 +3%	1 988 +2%	2 057 +3%	2 162 +5%	2 188 +1%	2 217 +1%	2 280 +3%	2 364 +4%	2 436 +3%	2 626 +8%	2 863 +9%	3 094 +8%	3 300 +7%	3 481 +5%	3 584 +3%	3 659 +2%	3 739 +2%	3 763 +1%	3 794 +1%	3 834 +1%	3 843 +0%	3 910 +2%	3 993 +2%	4 069 +2%	4 065 0%	4 087 +1%	4 158 +2%
Gross Profit
Cost of Revenue	(7)	(7)	(7)	(7)	(9)	(9)	(10)	(14)	(14)	(14)	(13)	(10)	(10)	(11)	(11)	(12)	(14)	(14)	(14)	(15)	(14)	(19)	(28)	(57)	(78)	(98)	(111)	(102)	(102)	(106)	(112)	(114)	(117)	(115)	(106)	(107)	(103)	(98)	(100)	(96)	(105)	(107)	(112)	(119)	(110)	(119)	(125)	(120)	(122)	(121)	(114)	(119)	(128)	(123)	(123)	(134)	(149)	(161)	(252)	(355)	(441)	(516)	(521)	(509)	(541)	(554)	(527)	(496)	(436)	(402)	(415)	(424)	(446)	(455)	(461)	(478)
Gross Profit	38 N/A	42 +10%	45 +8%	55 +22%	56 +2%	57 +1%	57 +0%	49 -13%	54 +9%	61 +15%	83 +36%	100 +20%	119 +19%	131 +10%	134 +2%	147 +10%	160 +9%	176 +10%	200 +13%	226 +13%	258 +14%	305 +18%	356 +17%	429 +21%	508 +18%	582 +15%	653 +12%	718 +10%	770 +7%	817 +6%	895 +9%	966 +8%	1 056 +9%	1 120 +6%	1 172 +5%	1 205 +3%	1 222 +1%	1 254 +3%	1 299 +4%	1 337 +3%	1 383 +3%	1 421 +3%	1 430 +1%	1 460 +2%	1 509 +3%	1 568 +4%	1 668 +6%	1 731 +4%	1 769 +2%	1 833 +4%	1 874 +2%	1 938 +3%	2 034 +5%	2 065 +2%	2 093 +1%	2 146 +3%	2 215 +3%	2 276 +3%	2 374 +4%	2 508 +6%	2 654 +6%	2 785 +5%	2 961 +6%	3 075 +4%	3 119 +1%	3 185 +2%	3 236 +2%	3 299 +2%	3 399 +3%	3 441 +1%	3 495 +2%	3 568 +2%	3 623 +2%	3 610 0%	3 625 +0%	3 679 +1%
Operating Income
Operating Expenses	(116)	(120)	(128)	(135)	(158)	(220)	(204)	(207)	(194)	(165)	(132)	(147)	(103)	(101)	(101)	(103)	(102)	(115)	(103)	(112)	(131)	(165)	(209)	(261)	(310)	(350)	(384)	(404)	(429)	(616)	(659)	(773)	(819)	(699)	(705)	(664)	(681)	(758)	(771)	(771)	(789)	(815)	(827)	(906)	(980)	(1 088)	(1 157)	(1 117)	(1 112)	(1 174)	(1 162)	(1 281)	(1 502)	(1 720)	(1 754)	(1 744)	(1 701)	(1 546)	(1 835)	(2 135)	(2 254)	(2 689)	(2 524)	(2 469)	(3 010)	(3 212)	(3 191)	(3 106)	(2 720)	(2 867)	(2 879)	(2 865)	(2 897)	(3 015)	(3 011)	(3 225)
Selling, General & Administrative	(51)	(53)	(58)	(63)	(79)	(97)	(113)	(119)	(111)	(93)	(72)	(63)	(59)	(61)	(65)	(68)	(69)	(72)	(77)	(90)	(109)	(133)	(168)	(198)	(224)	(249)	(269)	(284)	(303)	(340)	(363)	(381)	(404)	(410)	(416)	(427)	(448)	(464)	(480)	(500)	(501)	(517)	(527)	(527)	(544)	(607)	(633)	(665)	(684)	(644)	(662)	(685)	(737)	(777)	(793)	(821)	(854)	(906)	(1 067)	(1 222)	(1 223)	(1 278)	(1 252)	(1 207)	(1 376)	(1 325)	(1 340)	(1 330)	(1 262)	(1 370)	(1 367)	(1 385)	(1 385)	(1 548)	(1 567)	(1 772)
Research & Development	(55)	(57)	(60)	(62)	(70)	(76)	(81)	(76)	(70)	(60)	(49)	(45)	(37)	(31)	(28)	(28)	(26)	(23)	(19)	(15)	(14)	(15)	(13)	(17)	(21)	(27)	(34)	(40)	(47)	(181)	(192)	(276)	(288)	(170)	(178)	(131)	(135)	(148)	(159)	(171)	(186)	(191)	(194)	(254)	(283)	(301)	(315)	(244)	(227)	(280)	(289)	(369)	(410)	(582)	(599)	(556)	(587)	(375)	(426)	(478)	(506)	(559)	(635)	(643)	(1 035)	(1 095)	(1 096)	(1 182)	(850)	(883)	(895)	(860)	(884)	(842)	(811)	(809)
Depreciation & Amortization	(10)	(10)	(10)	(9)	(9)	(9)	(11)	(12)	(13)	(12)	(10)	(9)	(8)	(8)	(8)	(8)	(8)	(8)	(8)	(8)	(7)	(16)	(28)	(45)	(65)	(74)	(81)	(81)	(79)	(91)	(104)	(115)	(127)	(120)	(111)	(107)	(98)	(96)	(99)	(100)	(102)	(105)	(105)	(125)	(152)	(179)	(208)	(208)	(202)	(205)	(212)	(228)	(355)	(361)	(362)	(366)	(260)	(265)	(343)	(436)	(526)	(630)	(638)	(619)	(599)	(577)	(581)	(594)	(608)	(614)	(617)	(620)	(627)	(626)	(633)	(644)
Other Operating Expenses	0	0	0	0	0	(38)	0	0	0	0	0	(30)	0	0	0	0	0	(12)	0	0	0	0	0	0	0	0	0	0	0	(4)	0	0	0	0	0	0	0	(50)	(33)	0	0	0	0	0	0	0	0	0	0	(44)	0	0	0	0	0	0	0	0	0	0	0	(222)	0	0	0	(215)	(175)	0	0	0	0	0	0	0	0	0
Operating Income	(78) N/A	(78) 0%	(83) -5%	(80) +3%	(101) -27%	(163) -61%	(147) +10%	(157) -7%	(141) +11%	(104) +26%	(49) +53%	(47) +3%	16 N/A	30 +91%	33 +9%	44 +33%	58 +33%	61 +5%	96 +59%	116 +20%	128 +10%	140 +9%	147 +5%	169 +15%	198 +17%	232 +17%	269 +16%	314 +17%	342 +9%	202 -41%	236 +17%	193 -18%	237 +22%	421 +78%	467 +11%	541 +16%	541 +0%	496 -8%	528 +6%	566 +7%	593 +5%	606 +2%	602 -1%	555 -8%	529 -5%	481 -9%	512 +6%	614 +20%	658 +7%	659 +0%	712 +8%	656 -8%	532 -19%	345 -35%	339 -2%	402 +19%	514 +28%	730 +42%	539 -26%	373 -31%	399 +7%	96 -76%	437 +356%	606 +39%	109 -82%	(27) N/A	45 N/A	193 +327%	678 +252%	574 -15%	616 +7%	704 +14%	727 +3%	595 -18%	614 +3%	454 -26%
Pre-Tax Income
Interest Income Expense	(12)	(11)	(10)	(8)	(8)	(8)	(11)	(15)	(18)	(21)	(22)	(22)	(23)	(23)	(22)	(18)	(13)	(8)	(4)	(3)	(2)	(1)	(2)	(11)	(21)	(28)	(33)	(31)	(29)	(31)	(35)	(37)	(44)	(48)	(54)	(60)	(56)	(54)	(49)	(55)	(59)	(67)	(78)	(81)	(89)	(91)	(90)	(88)	(86)	(82)	(79)	(78)	(78)	(79)	(81)	(90)	(98)	(105)	(149)	(218)	(283)	(338)	(336)	(325)	(307)	(297)	(308)	(296)	(281)	(278)	(263)	(250)	(246)	(232)	(220)	(209)
Non-Reccuring Items	32	32	14	(18)	(38)	0	(20)	(20)	(30)	(30)	(30)	0	0	0	(12)	(12)	(12)	0	0	(1)	(1)	0	(2)	(1)	0	(1)	(5)	(5)	(5)	0	(33)	(33)	(41)	(42)	(26)	(26)	(50)	0	0	(33)	(2)	0	0	(2)	0	0	(44)	(44)	(44)	0	0	0	0	(136)	(141)	(141)	(141)	(5)	(78)	(79)	(229)	0	(186)	(359)	(174)	0	0	0	(100)	(55)	(55)	(55)	(10)	0	(905)	(948)
Gain/Loss on Disposition of Assets	0	5	5	5	6	1	1	5	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income	(1)	(4)	1	1	2	5	0	0	0	4	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Pre-Tax Income	(59) N/A	(57) +5%	(72) -28%	(99) -37%	(139) -40%	(166) -20%	(178) -7%	(187) -5%	(184) +2%	(151) +18%	(97) +36%	(69) +28%	(7) +90%	8 N/A	(1) N/A	14 N/A	33 +134%	53 +62%	93 +75%	112 +21%	125 +12%	139 +11%	144 +3%	158 +10%	177 +13%	203 +14%	231 +14%	278 +20%	308 +11%	170 -45%	167 -2%	124 -26%	152 +23%	331 +118%	387 +17%	455 +18%	436 -4%	441 +1%	479 +9%	478 0%	532 +11%	540 +1%	524 -3%	473 -10%	440 -7%	390 -11%	377 -3%	481 +28%	527 +10%	577 +9%	633 +10%	578 -9%	454 -21%	130 -71%	117 -10%	171 +46%	275 +61%	620 +125%	313 -50%	77 -75%	(113) N/A	(242) -115%	(85) +65%	(78) +9%	(373) -380%	(324) +13%	(263) +19%	(104) +61%	298 N/A	241 -19%	297 +23%	399 +34%	470 +18%	362 -23%	(511) N/A	(703) -38%
Net Income
Tax Provision	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(6)	(12)	(25)	84	72	55	49	(92)	(91)	(87)	(93)	(94)	(109)	(121)	(126)	(106)	(107)	(118)	(115)	(135)	(125)	(118)	(93)	(107)	(97)	(98)	(116)	(80)	(90)	25	34	73	154	20	12	(34)	(103)	(277)	(239)	(216)	(199)	46	71	159	174	183	187	120	93	99	67	91	121	107	335
Income from Continuing Operations	(59)	(57)	(72)	(99)	(139)	(166)	(178)	(187)	(184)	(151)	(97)	(69)	(7)	8	(1)	14	33	53	93	112	125	133	131	132	261	274	285	327	216	79	81	31	57	222	266	328	330	335	361	363	397	415	406	380	333	292	279	365	447	487	658	612	528	283	137	183	242	517	36	(163)	(329)	(441)	(39)	(7)	(214)	(150)	(81)	83	418	334	397	465	562	483	(404)	(368)
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Earnings Affiliates	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1)	(2)	(3)	(4)	(3)	(4)	(4)	(3)	1	4	2	(1)	(9)	(13)	(12)	(10)	(7)	(6)	(3)	(3)	(3)	(2)	(2)	(2)	(1)	(1)	(1)
Net Income (Common)	(81) N/A	(75) +8%	(91) -21%	(118) -30%	(139) -18%	(166) -20%	(178) -7%	(187) -5%	(184) +2%	(151) +18%	(97) +36%	(69) +28%	(7) +90%	8 N/A	(1) N/A	14 N/A	33 +134%	53 +62%	93 +75%	112 +21%	125 +12%	131 +5%	125 -5%	126 +1%	289 +130%	304 +5%	319 +5%	362 +13%	216 -40%	80 -63%	82 +2%	32 -61%	58 +82%	222 +280%	266 +20%	328 +23%	330 +0%	335 +2%	361 +8%	363 +0%	397 +9%	415 +5%	406 -2%	380 -6%	488 +28%	447 -8%	434 -3%	520 +20%	447 -14%	486 +9%	656 +35%	609 -7%	523 -14%	280 -46%	133 -52%	179 +34%	239 +33%	518 +117%	40 -92%	(161) N/A	(330) -105%	(450) -36%	(52) +88%	(19) +64%	(224) -1 098%	(156) +30%	(87) +45%	80 N/A	415 +419%	331 -20%	395 +19%	463 +17%	560 +21%	482 -14%	(405) N/A	(368) +9%
EPS (Diluted)	-3.31 N/A	-3.06 +8%	-3.7 -21%	-4.97 -34%	-10.04 -102%	-7 +30%	-7.44 -6%	-6.94 +7%	-7.19 -4%	-5.19 +28%	-3.32 +36%	-2.24 +33%	-0.23 +90%	0.23 N/A	-0.02 N/A	0.35 N/A	0.83 +137%	1.18 +42%	1.98 +68%	2.37 +20%	2.67 +13%	2.25 -16%	2.05 -9%	2.06 +0%	4.79 +133%	4.94 +3%	5.18 +5%	5.87 +13%	3.51 -40%	1.37 -61%	1.3 -5%	0.51 -61%	0.93 +82%	3.52 +278%	4.21 +20%	5.19 +23%	5.23 +1%	5.34 +2%	5.82 +9%	5.87 +1%	6.41 +9%	6.78 +6%	6.6 -3%	6.18 -6%	7.95 +29%	7.3 -8%	7.06 -3%	8.39 +19%	7.3 -13%	8.37 +15%	11.42 +36%	10.6 -7%	9.09 -14%	5 -45%	2.38 -52%	3.17 +33%	4.22 +33%	8.87 +110%	0.67 -92%	-2.62 N/A	-5.52 -111%	-7.15 -30%	-0.81 +89%	-0.3 +63%	-3.58 -1 093%	-2.11 +41%	-1.17 +45%	1.12 N/A	5.75 +413%	5.28 -8%	5.67 +7%	7.33 +29%	8.48 +16%	7.9 -7%	-6.61 N/A	-5.98 +10%

Income Statement Balance Sheet Cash Flow Statement

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Income Statement

Earnings Waterfall
Jazz Pharmaceuticals PLC

Income Statement
Jazz Pharmaceuticals PLC

See Also

Company

Help

Tools

Stocks

Jazz Pharmaceuticals PLC NASDAQ:JAZZ

Income Statement

Earnings Waterfall Jazz Pharmaceuticals PLC

Income Statement Jazz Pharmaceuticals PLC

See Also

Company

Help

Tools

Stocks

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Earnings Waterfall
Jazz Pharmaceuticals PLC

Income Statement
Jazz Pharmaceuticals PLC